Life Sciences

Beta Bionics Secures $100 Million for Artificial Pancre...

Beta Bionics, a Massachusetts-based company, has garnered a substantial infusion...

Rite Aid to file for bankruptcy to reorganize debt and ...

Rite Aid is reportedly on the brink of initiating a bankruptcy filing within the...

Novocure’s TTFields Misses the Mark in Phase 3 Ovarian ...

In a striking departure from earlier this year’s promising findings, Novocure’s ...

GE HealthCare introduces Vscan Air SL: a handheld ultra...

GE Healthcare has unveiled its latest innovation: the Vscan Air SL handheld ultr...

BridgeBio Explores Phase 3 Acoramidis Data in Depth

BridgeBio is delving deeper into the phase 3 research of acoramidis, focusing on...

Boston Scientific’s Farapulse System Irregular Heartbea...

Boston Scientific, a pioneering force in medical technology, has revealed clinic...

Self-adjusting spinal cord stimulator from Medtronic re...

While traditional systems for spinal cord stimulation play a significant role in...

Mallinckrodt Inching Closer to Second Bankruptcy Filing

Mallinckrodt has publicly disclosed its imminent initiation of the next phase of...

Roche posts encouraging interim study results for a lun...

Roche, the Swiss pharmaceutical giant, found itself inadvertently in the spotlig...

FDA Panel’s Divided Verdict Delays Approval for Medtron...

Medtronic’s pursuit of FDA approval for its blood pressure treatment device has ...

Regeneron receives FDA approval for longer-lasting visi...

The recent approvals signal a swifter turnaround for Regeneron than what analyst...

FDA greenlights Pfizer’s RSV vaccine for administration...

In a significant stride toward safeguarding the health of newborns, the Food and...

Spanish pharmaceutical company Serra Pamies faces EMA p...

The Serra Pamies facility located in Reus, Spain, has had its manufacturing oper...

Pfizer Slashes Enrollment For Lyme Disease Trial Follow...

Due to issues that arose with the CRO responsible for developing Pfizer’s Lyme d...

Hutchmed eyes Drug for autoimmune disease approved in C...

Hutchmed, a pharmaceutical company, is in the final stages of preparing a submis...

Setbacks continue for Gilead’s magrolimab in AML studie...

In a surprising turn of events, Gilead Sciences’ hopes for its magrolimab therap...